Optometry Job Board

Lumenis Ltd. a global developer, manufacturer and marketer of laser, light-based and radiofrequency devices for ophthalmic, surgical and aesthetic applications, announced today that it introduced a breakthrough ophthalmic laser delivery technology on October 24th at the American Academy of Ophthalmology (AAO) Annual Meeting in San Francisco, California, USA.

View post:
Breakthrough ophthalmic laser delivery technology introduced at the AAO Annual Meeting

Dr Vishali Gupta, Associate Professor, Advanced Eye Centre PGI received the prestigious Dr C Syamala Bhaskaran Award by the LV Prasad Eye Institute Hyderabad for her contribution to the practice of ophthalmology and research. The award was given in recognition of her significant contribution of her research in the field of intraocular inflammations and infections and other diseases of the retina including diabetic retinopathy and retinal imaging. She has published more than 65 papers on these su

Excerpt from:
Dr Vishali Gupta got Dr C Syamala Bhaskaran Award

Isotechnika Pharma Inc. today announced that results of the international Phase 2/3 clinical trials studying voclosporin, conducted by its partner Lux Biosciences, were the subject of two podium presentations at the American Association of Ophthalmology (AAO) meeting and of a presentation at the satellite meeting of the American Uveitis Society (AUS) in San Francisco, October 24-27.

Original post:
Isotechnika Pharma reports voclosporin Phase 2/3 clinical trial results at the AAO meeting

Our client is a 400 bed hospital in Al Ain, United Arab Emirates undergoing expansion and reconstruction. The hospital has a vacancy for a Consultant Ophthalmology Requirements: Candidates must hold a Board Certification from North America or Western Europe and a minimum of three years post board experience. The hospital offers an excellent benefit package comprising

Read more from the original source: 
Al Ain: Consultant Ophthalmology

SAN FRANCISCO— Today’s Scientific Program, 2009 American Academy of Ophthalmology (AAO) - Pan-American Association of Ophthalmology (PAAO) Joint Meeting, includes a Veterans Administration study that indicates that Iraq and Afghanistan veterans with vision loss from traumatic brain injury have significantly poorer quality of life than comparable civilian patients, and a Harvard doctor’s insights on how to best evaluate and care for low-vision patients who experience vivid visual hallucination

See the original post here:
TBI-vision loss impacts vets; low-vision patients may have hallucinations

For Immediate Release November 2, 2009 Contact: Media Relations (415) 561-8534 media@aao.org Cataract Surgery Benefits AMD Patients; Steroid Drug May Restore Vision in DME Patients; Top Online Eye Health Forums Analyzed Highlights of November 2009 “Ophthalmology” read more

Go here to see the original:
Cataract surgery helps AMD patients; steroid improves DME; online eye health forum

Nine-year-old Corey Haas can ride his bike alone now, thanks to an experimental gene therapy that has boosted his fading vision with a single treatment. The gene therapy helped improve worsening eyesight caused by a rare inherited disease called Leber congenital amaurosis, or LCA, which makes most patients blind by age 40. Twelve treated patients, including Corey, now have better vision, their doctors told a joint meeting of the American Academy of Ophthalmology and Pan-American Association

Read the original post: 
Gene therapy experiment restores sight in a few

Dealing a death blow to retinal degeneration the result of a rare inherited sight disorder, gene therapy trials counteracting the condition improved vision in all patients tested, including an 8-year old boy who recovered near normal sensitivity light Dr. Jean Bennett from the University of Pennsylvania, Philadelphia and colleagues reporting at the American Academy of Ophthalmology said, while all children with Leber’s congenital amaurosis treated in the study regained sufficient vision to wal

Original post:
Gene Therapy Death Knell For Rare Blindness

WASHINGTON - Children with congenital blindness may be able to improve their condition with gene therapy, say researchers. “Children who were treated with gene therapy are now able to walk and play just like any normally sighted child,” said study co-author Albert M. Maguire, associate professor of ophthalmology at Pennsylvania State University (PSU) and

Read the rest here: 
Shot of gene therapy may restore vision

Two studies are of particular note in today’s Scientific Program of the 2009 Joint Meeting of the American Academy of Ophthalmology (AAO) and the Pan-American Association of Ophthalmology (PAAO): a report by Swiss neuro-ophthalmic researchers about vision exam clues that should make ophthalmologists suspect an atypical variant of Alzheimer’s disease; and new evidence from a Singapore National Eye Center study that diabetics who are nearsighted may be less susceptible to diabetic retinopathy.

Here is the original post:
Study shows diabetics who are nearsighted may be less susceptible to diabetic retinopathy